Survival analysis identified two genes, IGFBP2 and IARS, whose high transcriptional levels were significantly associated with inferior overall survival of T-ALL patients (P = 0.012 for IGFBP2 and 0.036 for IARS, log-rank test) (Figure 6A and B). This evidence concerns the gene IGFBP2 and acute lymphoblastic leukemia.